Abstract
Fabry disease is a rare genetic disorder, which is linked to a defect of alfa-galactosidase. In consequence it leads to an excess of glicosphyngolipids in lysosomes of various tissues and organs. Clinical symptoms are related to heart, skin, kidneys and nervous system. Nowadays due to a possibility of substitution of galactosidase A, a influence on clinical course of the disease can be attained: arresting of progression and avoidance of complications.
MeSH terms
-
Disease Progression
-
Fabry Disease / diagnosis
-
Fabry Disease / genetics
-
Fabry Disease / physiopathology*
-
Fabry Disease / therapy
-
Female
-
Genetic Therapy
-
Humans
-
Isoenzymes / genetics
-
Isoenzymes / therapeutic use
-
Kidney / metabolism
-
Lysosomes / metabolism
-
Male
-
Rare Diseases / metabolism
-
Skin / metabolism
-
Trihexosylceramides / metabolism*
-
alpha-Galactosidase / genetics*
-
alpha-Galactosidase / therapeutic use*
Substances
-
Isoenzymes
-
Trihexosylceramides
-
alpha-Galactosidase